AceAge: Funding, Investors & Team (Sep 2026)
AceAge is a healthcare technology company, creating intuitive products to ease the aging process and improve health outcomes. AceAge is the company behind the next innovation in healthcare technology. Its upcoming product is a home health appliance designed to help people take their medication properly. Karie is a personal health companion that organizes, schedules, and dispenses pills with easy one-button control. The CEO of AceAge, Spencer Waugh, created Karie to increase the health and safety of medical patients, and as a way to minimize the negative consequences of missed medications or general failure to adhere to medication directions. The success of medicine is dependent on the patient’s compliance with the medical directions that accompany it, making it an integral part of healthcare. The total direct and indirect costs of nonadherence in the US annually is $290 billion. By making daily medicine routines completely automated, Karie removes the chance of human error. Karie uses common multi-dose pouch packaging that can be pre-set by pharmacists. Doses are scheduled, delivered and monitored for the user. Karie is easy to use, enables greater patient autonomy and ensures better healthcare through a highly coordinated program.
AceAge has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Dec 2020.
That round is in line with the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
AceAge Company Profile and Key Stats
Latest funding round on record: Dec 2020.
AceAge Funding Rounds
AceAge Founders and Leadership Team
Contact details for the AceAge team: 1 of 1 has an email address on file.
Start 14-day free trial →AceAge Funding Compared to Other Health Care Startups
AceAge's latest round of $5.0M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AceAge in Health Care and Waterloo
Companies Similar to AceAge
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
AceAge Funding FAQs
What does AceAge do?
AceAge is a healthcare technology company, creating intuitive products to ease the aging process and improve health outcomes. AceAge is the company behind the next innovation in healthcare technology. Its upcoming product is a home health appliance designed to help people take their medication properly. Karie is a personal health companion that organizes, schedules, and dispenses pills with easy one-button control. The CEO of AceAge, Spencer Waugh, created Karie to increase the health and safety of medical patients, and as a way to minimize the negative consequences of missed medications or general failure to adhere to medication directions. The success of medicine is dependent on the patient’s compliance with the medical directions that accompany it, making it an integral part of healthcare. The total direct and indirect costs of nonadherence in the US annually is $290 billion. By making daily medicine routines completely automated, Karie removes the chance of human error. Karie uses common multi-dose pouch packaging that can be pre-set by pharmacists. Doses are scheduled, delivered and monitored for the user. Karie is easy to use, enables greater patient autonomy and ensures better healthcare through a highly coordinated program.
How much funding has AceAge raised?
AceAge has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Dec 2020.
When did AceAge last raise funding?
AceAge's most recent funding round on record is an undisclosed round of $5.0M, announced in Dec 2020.
Who is the CEO of AceAge?
Spencer Waugh is listed as CEO at AceAge.
Where is AceAge headquartered?
AceAge is based in Waterloo, Ontario, Canada.
How many employees does AceAge have?
AceAge is in the 11-50 employee band.
How does AceAge's funding compare to other Health Care startups?
AceAge's latest round of $5.0M is in line with the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's AceAge Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AceAge is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.